Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients (DW-MSC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04535856
Recruitment Status : Completed
First Posted : September 2, 2020
Last Update Posted : January 27, 2021
Sponsor:
Collaborators:
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Daewoong Pharmaceutical Co. LTD.
Information provided by (Responsible Party):
Ina-Respond

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 14, 2021
Actual Study Completion Date : January 14, 2021